Economic dimensions of personalized and precision medicine (Book, 2019) []
skip to content
New coming soon
Economic dimensions of personalized and precision medicine

Economic dimensions of personalized and precision medicine

Author: Ernst R Berndt; Dana P Goldman; John Rowe, (Professor of Health Policy)
Publisher: Chicago ; London : The University of Chicago Press, 2019. ©2019
Series: National Bureau of Economic Research conference report.
Edition/Format:   Print book : Conference publication : English
"Advances in human genetics have begun to yield clinical benefits through the development of Precision Medicine (PM). The benefits of this innovation are promising, both through application of constitutional genetics detecting mutations that affect the risk of disease and tumor genetics, and malignancy-causing mutations susceptible to targeted therapies. While PM may ultimately be used in all aspects of medicine, to  Read more...
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...


Genre/Form: Congress
Conference papers and proceedings
Actes de congrès
Material Type: Conference publication
Document Type: Book
All Authors / Contributors: Ernst R Berndt; Dana P Goldman; John Rowe, (Professor of Health Policy)
ISBN: 9780226611068 022661106X
OCLC Number: 1050141922
Notes: "The event [conference] took the form of two sessions: a preconference at the Columbia University Italian Academy in New York City in September 2016, followed by a two-day research workshop at Shutters on the Beach Hotel in Santa Monica, CA, in September 2017."--Page ix.
Description: ix, 349 pages : illustrations ; 24 cm.
Contents: 1. The Economic Value and Pricing of Personalized Medicine / Tomas J. Philipson --
2. Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS / Jorge Lemus --
3. The Value of Pharmacogenomic Information / Josh F. Peterson --
4. The Information Pharms Race and Competitive Dynamics of Precision Medicine: Insights from Game Theory / Mark R. Trusheim --
5. Characterizing the Drug Development Pipeline for Precision Medicines / Ariel Dora Stern --
6. Cost Sharing in Insurance Coverage for Precision Medicine / Mark V. Pauly --
7. Measuring the Potential Health Impact of Personalized Medicine: Evidence from Multiple Sclerosis Treatments / Kristopher J. Hult --
8. Physicians' Financial Incentives to Personalize Medicine / Guy David --
9. Economic Dimensions of Personalized and Precision Medicine in Asia: Evidence from Breast Cancer Treatment in Taiwan / Joseph Tung-Chieh Chang --
10. The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger / Eric Wright --
11. Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies / Diego Useche.
Series Title: National Bureau of Economic Research conference report.
Responsibility: edited by Ernst R. Berndt, Dana P. Goldman, and John W. Rowe.


This volume explores the intersection of the scientific, clinical, and economic factors affecting the development of PPM, including its effects on the drug pipeline, on reimbursement of PPM  Read more...


Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.